Literature DB >> 2954533

A biphasic change in contractile proteins during the development of cardiac hypertrophy in pigs.

V Elimban, K S Dhalla, V Panagia, P K Singal, N S Dhalla.   

Abstract

A non-failing hypertrophy of the left ventricle was produced in the pig heart by supravalvular banding of aorta for 4, 8 and 12 weeks and the myosin and myofibrillar adenosine triphosphatase activities were measured. A significant increase in myosin Ca2+-ATPase activity was seen at 4 weeks of hypertrophy, but at 8 and 12 weeks this activity was significantly decreased compared to sham control. Similar changes were also seen in actin-activated myosin ATPase activities at 4, 8 and 12 weeks of hypertrophy. There were no changes in the K+- and NH4+-EDTA-stimulated ATPAse activities of myosin. Basal ATPase activities of myofibrils were decreased at 4 and 8 weeks of hypertrophy and there was no change in this activity at 12 weeks of hypertrophy. Ca2+ stimulated ATPase activity of myofibrils was significantly increased at 4 weeks, normal at 8 weeks and significantly reduced at 12 weeks of hypertrophy. The changes in ATPase activities were not due to any alterations of proteins by high concentrations of salts during the purification of myosin. The non-hypertrophied right ventricle from the banded animals did not show any change in the basal or Ca2+ stimulated myofibrillar ATPase activities. It is suggested that hypertrophy of the myocardium is accompanied by specific changes in the enzyme activities of the contractile proteins and the biphasic responses may correlate with the functional state of the myocardium subjected to a chronic increase in pressure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954533     DOI: 10.1007/bf01907047

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  32 in total

1.  Functional significance of altered myosin adenosine triphosphatase activity in enlarged hearts.

Authors:  N R Alpert; L A Mulieri; R Z Litten
Journal:  Am J Cardiol       Date:  1979-10-22       Impact factor: 2.778

2.  Biochemical studies on the sarcolemmal function in the hypertrophied rabbit heart.

Authors:  J M Lamers; J T Stinis; W J Kort; W C Hülsmann
Journal:  J Mol Cell Cardiol       Date:  1978-03       Impact factor: 5.000

3.  Sulfhydryl groups involved in the active site of myosin A adenosine triphosphatase. I. Specific blocking of the SH group responsible for the inhibitory phase in "B phasic response" of the catalytic activity.

Authors:  M Yamaguchi; T Sekine
Journal:  J Biochem       Date:  1966-01       Impact factor: 3.387

4.  Mitochondria and sarcoplasmic reticulum function in cardiac hypertrophy and failure.

Authors:  L A Sordahl; W B McCollum; W G Wood; A Schwartz
Journal:  Am J Physiol       Date:  1973-03

5.  Myofibrillar and actomyosin adenosine-tri-phosphatase in experimental aortic insufficiency.

Authors:  B Swynghedauw; P Bouveret; M Durand; P Y Hatt; F Lemaire; V Piguet
Journal:  Cardiovasc Res       Date:  1971-10       Impact factor: 10.787

6.  The myocardium in hyperfunction, hypertrophy and heart failure.

Authors:  F Z Meerson
Journal:  Circ Res       Date:  1969-07       Impact factor: 17.367

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Effects of physical training on cardiac myosin ATPase activity.

Authors:  A K Bhan; J Scheuer
Journal:  Am J Physiol       Date:  1975-04

9.  Purification of cardiac myosin. Application to hypertrophied myocardium.

Authors:  K T Shiverick; L L Thomas; N R Alpert
Journal:  Biochim Biophys Acta       Date:  1975-05-30

10.  The amino acid composition of actin and myosin and Ca2+-activated myosin adenosine triphosphatase in chronic canine congestive heart failure.

Authors:  R R Raszkowski; J D Welty; M B Peterson
Journal:  Circ Res       Date:  1977-02       Impact factor: 17.367

View more
  1 in total

1.  Effects of some L-carnitine derivatives on heart membrane ATPases.

Authors:  N S Dhalla; F Kolár; K R Shah; R Ferrari
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.